Literature DB >> 11316776

Effects of cartilage-derived morphogenetic proteins and osteogenic protein-1 on osteochondrogenic differentiation of periosteum-derived cells.

R Gruber1, C Mayer, K Bobacz, M T Krauth, W Graninger, F P Luyten, L Erlacher.   

Abstract

Localization studies and genetic evidence have implicated cartilage-derived morphogenetic proteins-1, -2 (CDMP-1 and CDMP-2), and osteogenic protein-1 (OP-1) in the osteochondrogenic differentiation of mesenchymal progenitor cells during embryonic development and in postnatal life. Based on their expression pattern and the evidence that periosteum contains mesenchymal cells in the cambium layer that can undergo bone and cartilage formation, we hypothesized that CDMPs and OP-1 may be involved in long bone development and fracture healing. To test this hypothesis, periosteum-derived cells from young calves were cultured as monolayers under serum-free conditions with and without the addition of recombinant CDMP-1, CDMP-2 and OP-1. Phenotypic analysis indicate that periosteum-derived cell populations prepared, expanded, and cultured under the conditions described below, constitutively express messenger RNAs for the bone markers osteocalcin, osteopontin and collagen type I, and the chondrogenic markers collagen type II and aggrecan as determined by RT-PCR. Moreover, histologic examinations showed positive staining for alcian blue and alkaline phosphatase (AP). Treatment of periosteum-derived cells with CDMPs and OP-1 resulted in a dose-dependent increase of cell proliferation; CDMP-2 was less active in this regard. Furthermore, all growth factors enhanced osteogenic differentiation as assessed by a time- and dose-dependent stimulation of AP activity and OP-1 increased messenger RNA expression for osteocalcin and collagen type I. We further examined the effects of CDMPs and OP-1 on chondrogenic differentiation of periosteum-derived cells. Both CDMPs and OP-1 stimulated (35)S-sulfate incorporation into newly synthesized macromolecules with OP-1 having a more pronounced stimulatory effect when compared with CDMP-1 and CDMP-2. Our results indicate that distinct members of the BMP-family increase the mitotic and metabolic activity of periosteum-derived cells. The enhancement of both the chondrogenic and osteogenic differentiation suggests that these growth factors might contribute to the local regulation of bone formation and fracture repair.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316776     DOI: 10.1210/endo.142.5.8163

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

1.  Human periosteum-derived stem cells for tissue engineering applications: the role of VEGF.

Authors:  C Ferretti; V Borsari; M Falconi; A Gigante; R Lazzarini; M Fini; R Di Primio; M Mattioli-Belmonte
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  BMP7 can promote osteogenic differentiation of human periosteal cells in vitro.

Authors:  Kangsheng Bei; Zhipo Du; Yinghui Xiong; Jiacheng Liao; Baojin Su; Liyang Wu
Journal:  Mol Biol Rep       Date:  2012-06-27       Impact factor: 2.316

Review 3.  Periosteum derived stem cells for regenerative medicine proposals: Boosting current knowledge.

Authors:  Concetta Ferretti; Monica Mattioli-Belmonte
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

Review 4.  Clinical considerations of regenerative medicine in osteoporosis.

Authors:  Hiromu Ito
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

5.  Stimulatory effects of distinct members of the bone morphogenetic protein family on ligament fibroblasts.

Authors:  K Bobacz; R Ullrich; L Amoyo; L Erlacher; J S Smolen; W B Graninger
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

6.  Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer.

Authors:  Andre F Steinert; Glyn D Palmer; Carmencita Pilapil; Ulrich Nöth; Christopher H Evans; Steven C Ghivizzani
Journal:  Tissue Eng Part A       Date:  2009-05       Impact factor: 3.845

7.  No effect of subperiosteal growth factor application on periosteal neo-chondrogenesis in osteoperiosteal bone grafts for osteochondral defect repair.

Authors:  Tobias Gotterbarm; Steffen J Breusch; Simona Berardi Vilei; Pierre Mainil-Varlet; Wiltrud Richter; Martin Jung
Journal:  Int Orthop       Date:  2013-03-17       Impact factor: 3.075

8.  Are bone turnover markers associated with volumetric bone density, size, and strength in older men and women? The AGES-Reykjavik study.

Authors:  E A Marques; V Gudnason; G Sigurdsson; T Lang; F Johannesdottir; K Siggeirsdottir; L Launer; G Eiriksdottir; T B Harris
Journal:  Osteoporos Int       Date:  2015-12-02       Impact factor: 4.507

Review 9.  Concepts in gene therapy for cartilage repair.

Authors:  Andre F Steinert; Ulrich Nöth; Rocky S Tuan
Journal:  Injury       Date:  2008-04       Impact factor: 2.586

Review 10.  Cartilage morphogenetic proteins: role in joint development, homoeostasis, and regeneration.

Authors:  A H Reddi
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.